318 related articles for article (PubMed ID: 19267370)
1. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.
Wang MH; Helzlsouer KJ; Smith MW; Hoffman-Bolton JA; Clipp SL; Grinberg V; De Marzo AM; Isaacs WB; Drake CG; Shugart YY; Platz EA
Prostate; 2009 Jun; 69(8):874-85. PubMed ID: 19267370
[TBL] [Abstract][Full Text] [Related]
2. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer.
Tsilidis KK; Helzlsouer KJ; Smith MW; Grinberg V; Hoffman-Bolton J; Clipp SL; Visvanathan K; Platz EA
Cancer Causes Control; 2009 Nov; 20(9):1739-51. PubMed ID: 19760027
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk.
Huang BZ; Tsilidis KK; Smith MW; Hoffman-Bolton J; Visvanathan K; Platz EA; Joshu CE
Mol Carcinog; 2018 Oct; 57(10):1278-1288. PubMed ID: 29802748
[TBL] [Abstract][Full Text] [Related]
4. Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence.
Dluzniewski PJ; Wang MH; Zheng SL; De Marzo AM; Drake CG; Fedor HL; Partin AW; Han M; Fallin MD; Xu J; Isaacs WB; Platz EA
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1774-82. PubMed ID: 22859398
[TBL] [Abstract][Full Text] [Related]
5. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2017 Jun; 77(8):908-919. PubMed ID: 28317149
[TBL] [Abstract][Full Text] [Related]
6. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
[TBL] [Abstract][Full Text] [Related]
7. Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.
Winchester DA; Gurel B; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Thompson IM; Xu J; Zheng SL; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; Drake CG; De Marzo AM; Platz EA
Prostate; 2016 May; 76(6):565-74. PubMed ID: 26771888
[TBL] [Abstract][Full Text] [Related]
8. Association of variants in genes related to the immune response and obesity with BPH in CLUE II.
Lopez DS; Peskoe SB; Tsilidis KK; Hoffman-Bolton J; Helzlsouer KJ; Isaacs WB; Smith MW; Platz EA
Prostate Cancer Prostatic Dis; 2014 Dec; 17(4):353-8. PubMed ID: 25224558
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the promoter region of IL10 gene are associated with virus etiology of infant bronchiolitis.
Holster A; Teräsjärvi J; Vuononvirta J; Koponen P; Peltola V; Helminen M; He Q; Korppi M; Nuolivirta K
World J Pediatr; 2018 Dec; 14(6):594-600. PubMed ID: 29802545
[TBL] [Abstract][Full Text] [Related]
10. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in RNASEL associated with prostate cancer risk and progression.
Meyer MS; Penney KL; Stark JR; Schumacher FR; Sesso HD; Loda M; Fiorentino M; Finn S; Flavin RJ; Kurth T; Price AL; Giovannucci EL; Fall K; Stampfer MJ; Ma J; Mucci LA
Carcinogenesis; 2010 Sep; 31(9):1597-603. PubMed ID: 20576793
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.
Shui IM; Stark JR; Penney KL; Schumacher FR; Epstein MM; Pitt MJ; Stampfer MJ; Tamimi RM; Lindstrom S; Sesso HD; Fall K; Ma J; Kraft P; Giovannucci E; Mucci LA
Prostate; 2012 Feb; 72(2):209-16. PubMed ID: 21563195
[TBL] [Abstract][Full Text] [Related]
13. Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan.
Tsai CW; Tsai MH; Shih LC; Chang WS; Lin CC; Bau DT
Anticancer Res; 2013 Aug; 33(8):3391-6. PubMed ID: 23898109
[TBL] [Abstract][Full Text] [Related]
14. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
15. Genetic modifications of cytokine genes and Toxoplasma gondii infections in pregnant women.
Wujcicka W; Wilczyński J; Śpiewak E; Nowakowska D
Microb Pathog; 2018 Aug; 121():283-292. PubMed ID: 29859292
[TBL] [Abstract][Full Text] [Related]
16. Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women.
Datta A; Tuz Zahora F; Abdul Aziz M; Sarowar Uddin M; Ferdous M; Shalahuddin Millat M; Shahid Sarwar M; Abdul Barek M; Jafrin S; Nahar S; Safiqul Islam M
Int Immunopharmacol; 2020 Dec; 89(Pt B):107091. PubMed ID: 33069925
[TBL] [Abstract][Full Text] [Related]
17. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Setiawan VW; Schumacher FR; Haiman CA; Stram DO; Albanes D; Altshuler D; Berglund G; Buring J; Calle EE; Clavel-Chapelon F; Cox DG; Gaziano JM; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn J; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Ma J; Le Marchand L; Linseisen J; Lund E; Navarro C; Overvad K; Palli D; Peeters PH; Pike MC; Riboli E; Stampfer MJ; Thun MJ; Travis R; Trichopoulos D; Yeager M; Ziegler RG; Spencer Feigelson H; Chanock SJ
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2237-46. PubMed ID: 18006912
[TBL] [Abstract][Full Text] [Related]
18. Genetic variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects susceptibility and their circulating serum levels: An explorative study of prostate cancer patients in North Indian populations.
Dwivedi S; Goel A; Khattri S; Mandhani A; Sharma P; Misra S; Pant KK
Cytokine; 2015 Jul; 74(1):117-22. PubMed ID: 25892571
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
Fesinmeyer MD; Kwon EM; Fu R; Ostrander EA; Stanford JL
Prostate; 2011 Oct; 71(14):1538-47. PubMed ID: 21360564
[TBL] [Abstract][Full Text] [Related]
20. Ancestry informative markers and selected single nucleotide polymorphisms in immunoregulatory genes on preterm labor and preterm premature rupture of membranes: a case control study.
Ramos BR; Mendes ND; Tanikawa AA; Amador MA; dos Santos NP; dos Santos SE; Castelli EC; Witkin SS; da Silva MG
BMC Pregnancy Childbirth; 2016 Feb; 16():30. PubMed ID: 26846412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]